tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

NBTX Stock Latest News

Nanobiotix Discloses Managerial Transactions to Enhance Financial Flexibility
Company AnnouncementsNanobiotix Discloses Managerial Transactions to Enhance Financial Flexibility
10d ago
6K
NBTX
Strategic Financial and Operational Advancements Propel Nanobiotix to a Buy Rating
PremiumRatings
Strategic Financial and Operational Advancements Propel Nanobiotix to a Buy Rating
16d ago
NBTX
Nanobiotix Secures $71 Million Financing and Advances Cancer Treatment Programs
PremiumCompany Announcements
Nanobiotix Secures $71 Million Financing and Advances Cancer Treatment Programs
17d ago
6K
NBTX
Nanobiotix Advances Curadigm Nanoprimer Platform with New Patents and Preclinical Data
PremiumCompany Announcements
Nanobiotix Advances Curadigm Nanoprimer Platform with New Patents and Preclinical Data
27d ago
6K
NBTX
Nanobiotix Announces Updated Voting Rights and Share Capital
PremiumCompany Announcements
Nanobiotix Announces Updated Voting Rights and Share Capital
28d ago
6K
NBTX
Nanobiotix to Present at Jefferies London Healthcare Conference
PremiumCompany AnnouncementsNanobiotix to Present at Jefferies London Healthcare Conference
30d ago
6K
NBTX
Nanobiotix price target raised to EUR 23 from EUR 20 at H.C. Wainwright
Premium
The Fly
Nanobiotix price target raised to EUR 23 from EUR 20 at H.C. Wainwright
1M ago
NBTX
Nanobiotix’s Strategic Financing and Clinical Expansion Signal Strong Buy Opportunity
Premium
Ratings
Nanobiotix’s Strategic Financing and Clinical Expansion Signal Strong Buy Opportunity
1M ago
NBTX
Nanobiotix to Present at Key November Investor Conferences
PremiumCompany Announcements
Nanobiotix to Present at Key November Investor Conferences
1M ago
6K
NBTX
Nanobiotix Secures $71 Million Royalty Agreement with HealthCare Royalty
PremiumCompany Announcements
Nanobiotix Secures $71 Million Royalty Agreement with HealthCare Royalty
1M ago
6K
NBTX
Nanobiotix enters royalty-based financing pact with HealthCare Royalty for $71M
PremiumThe Fly
Nanobiotix enters royalty-based financing pact with HealthCare Royalty for $71M
1M ago
NBTX
Nanobiotix Transfers Phase 3 Trial Control to J&J, Updates on NBTXR3 Program
PremiumCompany Announcements
Nanobiotix Transfers Phase 3 Trial Control to J&J, Updates on NBTXR3 Program
2M ago
6K
NBTX
Nanobiotix provides update on JNJ-1900 after Johnson & Johnson transfer
PremiumThe FlyNanobiotix provides update on JNJ-1900 after Johnson & Johnson transfer
2M ago
JNJ
NBTX
Nanobiotix Updates Voting Rights and Share Capital Details
Premium
Company Announcements
Nanobiotix Updates Voting Rights and Share Capital Details
2M ago
6K
NBTX
Nanobiotix SA ADR Reports Revenue Surge Amid Strategic Advances
Premium
Company Announcements
Nanobiotix SA ADR Reports Revenue Surge Amid Strategic Advances
2M ago
NBTX
Nanobiotix price target raised to EUR 20 from EUR 13 at H.C. Wainwright
PremiumThe Fly
Nanobiotix price target raised to EUR 20 from EUR 13 at H.C. Wainwright
2M ago
NBTX
Nanobiotix Reports Promising Phase 1 Results for Esophageal Cancer Treatment
PremiumCompany Announcements
Nanobiotix Reports Promising Phase 1 Results for Esophageal Cancer Treatment
2M ago
6K
NBTX
Nanobiotix presents data from JNJ-1900 dose escalation, expansion study cohorts
PremiumThe Fly
Nanobiotix presents data from JNJ-1900 dose escalation, expansion study cohorts
2M ago
JNJ
NBTX
Nanobiotix Reports Half-Year 2025 Financial Results and Strategic Progress
PremiumCompany Announcements
Nanobiotix Reports Half-Year 2025 Financial Results and Strategic Progress
2M ago
6K
NBTX
Nanobiotix Releases Half-Year Financial Report Highlighting JNJ-1900 Developments
PremiumCompany AnnouncementsNanobiotix Releases Half-Year Financial Report Highlighting JNJ-1900 Developments
2M ago
6K
NBTX
Nanobiotix Reveals Promising Phase 1 Results for JNJ-1900 in Cancer Treatment
Premium
Company Announcements
Nanobiotix Reveals Promising Phase 1 Results for JNJ-1900 in Cancer Treatment
2M ago
6K
NBTX
Nanobiotix price target raised to EUR 13 from EUR 10 at H.C. Wainwright
Premium
The Fly
Nanobiotix price target raised to EUR 13 from EUR 10 at H.C. Wainwright
3M ago
NBTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >